InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Keenan Greg. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 3 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €247k. History available since 28 February 2025. The latest transaction was disclosed on 1 August 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations